Response by Omland et al to Letter Regarding Article, "Sacubitril/Valsartan and Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy: The PRADA II Randomized Clinical Trial"

Affiliations

• ¹ K.G. Jebsen Centre for Cardiac Biomarkers, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway (T.O., S.L.H., M.N.G., G.G.).
• ² Department of Cardiology, Division of Medicine, Akershus University Hospital, Lørenskog, Norway (T.O.).
• ³ Department of Diagnostic Imaging, Akershus University Hospital, Lørenskog, Norway (S.L.H).
• ⁴ Department of Circulation and Medical Imaging, NTNU-Norwegian University of Science and Technology, Trondheim, Norway (E.H.).
• ⁵ Department of Cardiology and Cardiothoracic Surgery, St. Olavs Hospital, Trondheim, Norway (E.H., M.N.G.).
• ⁶ Department of Cardiology, Division of Medicine, Oslo University Hospital, Ullevål, Oslo, Norway (G.G.).
• ⁷ Department of Stroke, St. Olavs Hospital, Trondheim, Norway (T.W.).
• ⁸ Department of Neuromedicine and Movement Science, NTNU-Norwegian University of Science and Technology, Trondheim, Norway (T.W.).